VIVUS to Present at Upcoming Investor Conference

VIVUS to Present at Upcoming Investor Conference

MOUNTAIN VIEW, Calif., Jan. 13, 2014 (GLOBE NEWSWIRE) -- VIVUS, Inc.
(Nasdaq:VVUS) today announced that management will present an overview of the
company at the following investment conference:

32^nd Annual J.P. Morgan Healthcare Conference
January 15, 2014, 3:30pm PST
Westin St. Francis Hotel, San Francisco, California

A live webcast and 30-day archive of the presentation will be available at


VIVUS is a biopharmaceutical company commercializing and developing
innovative, next-generation therapies to address unmet needs in obesity, sleep
apnea, diabetes and sexual health. For more information about the company,
please visit

Certain statements in this press release are forward-looking within the
meaning of the Private Securities Litigation Reform Act of 1995. These
statements may be identified by the use of forward-looking words such as
"anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely,"
"may," "plan," "potential," "predict," "opportunity" and "should," among
others. There are a number of factors that could cause actual events to differ
materially from those indicated by such forward-looking statements. VIVUS does
not undertake an obligation to update or revise any forward-looking
statements. Investors should read the risk factors set forth in VIVUS's Form
10-K for the year ending December 31, 2012, as amended by the Form 10-K/A
filed on April 30, 2013 and by the Form 10-K/A filed on June 12, 2013, and
periodic reports filed with the Securities and Exchange Commission.

         Dana B Shinbaum
         Corporate Development & Investor Relations
         Investor Relations:
         The Trout Group
         Brian Korb
Press spacebar to pause and continue. Press esc to stop.